<DOC>
	<DOCNO>NCT01463111</DOCNO>
	<brief_summary>Forty subject bipolar disorder receive mood-stabilizing medication treatment illness participate study . The study aim evaluate decision-making affect treatment bipolar disorder . Prior begin treatment , patient complete questionnaire one-hour computer-administered assessment decision-making . Differences pre-post decision-making outcome evaluate examine whether neuroeconomic concept risk aversion , loss aversion , risk tolerance delay discounting affect treatment . The overall goal study identify whether decision-making people bipolar disorder affect treatment . Specifically investigator compare decision-making characteristic among bipolar patient prior treatment decision-making characteristic change course 6 week standard medication therapy bipolar disorder . A total 6 decision-making task one control task administer via computer eligible subject . The investigator evaluate decision-making varying condition reward , risk , uncertainty time . The investigator hypothesize decision-making improve across assessment 6 week treatment .</brief_summary>
	<brief_title>Decision-Making Bipolar Disorder</brief_title>
	<detailed_description>Participation study require three study visit 6 week . Subjects evaluate Structured Diagnostic Interview DSM-IV confirm diagnosis . They also administer Hamilton Anxiety Depression Rating Scales . Eligible subject complete questionnaire relate symptom well decision-making risk-taking , include : Barratt Impulsiveness Scale , Spielberger State-Trait Anxiety Inventory , Flinders Decision-making questionnaire . The Montgomery-Asburg Depression Severity scale ass change depression symptom severity Young Mania Rating Scale ass change manic symptom severity , conduct screening , baseline , endpoint . Patients also give Childhood Trauma Questionnaire baseline visit , assess history childhood trauma . The subject complete computer-generated decision-making task . Upon completion , study physician initiate standard-of-care treatment mood stabilizer ( either lithium , valproate , lamotrigine ) . Standard-of-care laboratory test psychiatric follow-up perform patient 's study participation . After six week treatment mood stabilizer , patient complete decision-making computerized assessment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>1 . Male female , age 1865 2 . Primary DSMIV TR Diagnosis Bipolar Disorder , type I , II NOS . 3 . Ability visually read understand English language 4 . Not currently take mood stabilizer antipsychotic medication . 5 . Women reproductive potential must willing take medically approve form birth control throughout duration study . 1 . Meet criterion substance abuse dependence within three month screen visit . 2 . Presents clinically significant suicide risk , assess study physician . 3 . Presence unstable central nervous systemrelated medical illness would interfere cognition participation . 4 . Women currently pregnant lactate , plan become pregnant study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Bipolar</keyword>
	<keyword>Manic depression</keyword>
	<keyword>Mood stabilizer</keyword>
	<keyword>Decision</keyword>
	<keyword>Neuroeconomics</keyword>
</DOC>